Variant report
Variant | nsv983615 |
---|---|
Chromosome Location | chr13:95410835-95413290 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:244)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr13:95410779-95410835 | Kidney_OC | kidney: | n/a | n/a |
2 | E2F6 | chr13:95411540-95411670 | K562 | blood: | n/a | chr13:95411544-95411553 |
3 | FOS | chr13:95411709-95411920 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | KAP1 | chr13:95410426-95411395 | HEK293 | kidney: | n/a | n/a |
5 | KAP1 | chr13:95410754-95411400 | U2OS | brain: | n/a | n/a |
6 | SETDB1 | chr13:95410481-95411460 | U2OS | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:95412246-95412296 | HEK293 | kidney: | embryo |
2 | chr13:95412246-95412296 | PrEC | prostate: | n/a |
3 | chr13:95411394-95411444 | GM19239 | blood: | n/a |
4 | chr13:95411654-95411704 | BJ | skin: | n/a |
5 | chr13:95412246-95412296 | Jurkat | blood: | n/a |
6 | chr13:95411654-95411704 | HRCEpiC | kidney: | n/a |
7 | chr13:95412246-95412296 | AG09309 | skin: | n/a |
8 | chr13:95412246-95412296 | HNPCEpiC | eye: | n/a |
9 | chr13:95411394-95411444 | HCPEpiC | choroid plexus: | n/a |
10 | chr13:95411654-95411704 | NH-A | brain: | n/a |
11 | chr13:95411504-95411554 | NHBE | bronchial: | n/a |
12 | chr13:95411504-95411554 | GM12892 | blood: | n/a |
13 | chr13:95411654-95411704 | AG09309 | skin: | n/a |
14 | chr13:95412246-95412296 | SK-N-SH_RA | brain: | n/a |
15 | chr13:95411504-95411554 | PFSK-1 | brain: | n/a |
16 | chr13:95412246-95412296 | SK-N-MC | brain: | n/a |
17 | chr13:95411504-95411554 | U87 | brain: | n/a |
18 | chr13:95411394-95411444 | HEK293 | kidney: | embryo |
19 | chr13:95411394-95411444 | NHBE | bronchial: | n/a |
20 | chr13:95411504-95411554 | HIPEpiC | eye: | n/a |
21 | chr13:95411504-95411554 | ProgFib | skin: | n/a |
22 | chr13:95411394-95411444 | AG09309 | skin: | n/a |
23 | chr13:95411654-95411704 | Caco-2 | colon: | n/a |
24 | chr13:95411504-95411554 | AG09309 | skin: | n/a |
25 | chr13:95411654-95411704 | SAEC | small airway: | n/a |
26 | chr13:95411394-95411444 | HCT-116 | colon: | n/a |
27 | chr13:95411654-95411704 | PANC-1 | pancreas: | n/a |
28 | chr13:95411504-95411554 | GM06990 | blood: | n/a |
29 | chr13:95411654-95411704 | A549 | lung: | n/a |
30 | chr13:95411504-95411554 | HMEC | breast: | n/a |
31 | chr13:95411654-95411704 | GM12891 | blood: | n/a |
32 | chr13:95411394-95411444 | PrEC | prostate: | n/a |
33 | chr13:95411394-95411444 | NH-A | brain: | n/a |
34 | chr13:95411504-95411554 | AG04450 | lung: | fetal |
35 | chr13:95411394-95411444 | GM06990 | blood: | n/a |
36 | chr13:95412246-95412296 | AG04449 | skin: | fetal |
37 | chr13:95411504-95411554 | AG10803 | skin: | n/a |
38 | chr13:95411394-95411444 | SK-N-SH_RA | brain: | n/a |
39 | chr13:95412246-95412296 | HepG2 | liver: | n/a |
40 | chr13:95411394-95411444 | AG09319 | gingival: | n/a |
41 | chr13:95411504-95411554 | PANC-1 | pancreas: | n/a |
42 | chr13:95411504-95411554 | GM12878 | blood: | n/a |
43 | chr13:95411394-95411444 | BJ | skin: | n/a |
44 | chr13:95412246-95412296 | HPAEpiC | pulmonary alveolar: | n/a |
45 | chr13:95411394-95411444 | PFSK-1 | brain: | n/a |
46 | chr13:95411654-95411704 | CMK | blood: | n/a |
47 | chr13:95411654-95411704 | Jurkat | blood: | n/a |
48 | chr13:95411394-95411444 | HPAEpiC | pulmonary alveolar: | n/a |
49 | chr13:95412246-95412296 | GM06990 | blood: | n/a |
50 | chr13:95411504-95411554 | HL-60 | blood: | n/a |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GPR180-2 | chr13:95413195-95413306 | NONHSAT034743 |
2 | lnc-GPR180-2 | chr13:95413195-95413306 | ENSG00000250280 |
3 | lnc-SOX21-4 | chr13:95412807-95413269 | NONHSAT034742 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL21P112 | TF binding region |
BRD7P5 | TF binding region |
RPL21P112 | CpG island |
BRD7P5 | CpG island |
RNF213 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188791713 | chr13:95410851-95410852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79225777 | chr13:95410861-95410862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549955135 | chr13:95410867-95410868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569839947 | chr13:95410972-95410973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529247877 | chr13:95411004-95411005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1830706 | chr13:95411010-95411011 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs181275484 | chr13:95411101-95411102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113717964 | chr13:95411104-95411105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554281359 | chr13:95411122-95411123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570929994 | chr13:95411131-95411132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539605884 | chr13:95411262-95411263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556758497 | chr13:95411265-95411266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151170224 | chr13:95411278-95411279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542145065 | chr13:95411283-95411284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555655720 | chr13:95411287-95411288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1924075 | chr13:95411309-95411310 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs1924076 | chr13:95411339-95411340 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs74104391 | chr13:95411355-95411356 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs533086512 | chr13:95411364-95411365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74104393 | chr13:95411380-95411381 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs73558360 | chr13:95411390-95411391 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs187134368 | chr13:95411422-95411423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9516470 | chr13:95411450-95411451 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs202213646 | chr13:95411560-95411561 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs552529283 | chr13:95411570-95411571 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs367860632 | chr13:95411571-95411572 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs377652318 | chr13:95411577-95411578 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs191621454 | chr13:95411588-95411589 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs527640835 | chr13:95411592-95411593 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs7330924 | chr13:95411600-95411601 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs570847904 | chr13:95411620-95411621 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs539971242 | chr13:95411635-95411636 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs7329702 | chr13:95411656-95411657 | Weak transcription | TF binding regionCpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs140154285 | chr13:95411692-95411693 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs535672719 | chr13:95411695-95411696 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs555594228 | chr13:95411745-95411746 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs572414509 | chr13:95411750-95411751 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs534307494 | chr13:95411767-95411768 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs557778403 | chr13:95411802-95411803 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs544765954 | chr13:95411841-95411842 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs183484670 | chr13:95411860-95411861 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs543536765 | chr13:95411868-95411869 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs538831497 | chr13:95411874-95411875 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs372247489 | chr13:95411940-95411941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1885993 | chr13:95411980-95411981 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs374614582 | chr13:95412000-95412001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559648245 | chr13:95412024-95412025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528436829 | chr13:95412062-95412063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547472079 | chr13:95412066-95412067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79571495 | chr13:95412124-95412125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:95409600-95412800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr13:95410600-95413200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr13:95412600-95413600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr13:95412800-95413200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr13:95412800-95413200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr13:95412800-95413400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr13:95412800-95413600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr13:95412800-95413800 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr13:95412800-95414400 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr13:95412800-95414600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr13:95413000-95413800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr13:95413000-95414200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr13:95413200-95413800 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
14 | chr13:95413200-95414000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
15 | chr13:95413200-95414200 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
16 | chr13:95413200-95414600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |